ENDRA Life Sciences (NDRA) Notes Payables (2016 - 2020)
ENDRA Life Sciences (NDRA) has disclosed Notes Payables for 4 consecutive years, with $38402.0 as the latest value for Q1 2020.
- Quarterly Notes Payables changed N/A to $38402.0 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $38402.0 through Mar 2020, changed N/A year-over-year, with the annual reading at $298069.0 for FY2019, N/A changed from the prior year.
- Notes Payables for Q1 2020 was $38402.0 at ENDRA Life Sciences, down from $298069.0 in the prior quarter.
- The five-year high for Notes Payables was $1.1 million in Q1 2017, with the low at $38402.0 in Q1 2020.
- Average Notes Payables over 4 years is $435088.4, with a median of $298069.0 recorded in 2019.